The Non-Malignant Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2024 | Changes in physical, mental, and social health of adults with SCD following alloSCT
Elisabeth Dovern, MD, Amsterdam UMC, Amsterdam, Netherlands, discusses a study investigating patient-reported outcomes of allogeneic stem cell transplantation (alloSCT) in sickle cell disease (SCD). The study found that 18 months post-alloSCT, patients reported improvements in physical function, pain, fatigue, and social functioning. However, qualitative interviews indicated that some patients needed support to address mental health challenges. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
